Cardiac electrophysiology

BERLIN HEALS Announces results of first-in-human study for its Implantable C-MIC device for the Treatment of Heart Failure with Electrical Microcurrent and the Launch of a pivotal CE Mark Study

Thursday, March 4, 2021 - 4:00pm

The C-MIC is a small implantable device that delivers a minimal constant electrical DC current to the heart.

Key Points: 
  • The C-MIC is a small implantable device that delivers a minimal constant electrical DC current to the heart.
  • The results show significant, rapid improvements in heart function, heart size and quality of life of patients.
  • Thus, this treatment has the potential to become the first sustainable, almost curative, treatment for heart failure in patients with unmet medical needs.
  • Since 2014, the Berlin Heals team has been developing a new and revolutionary technology to treat heart failure.

Acutus Medical Appoints Duane Wilder as Chief Commercial Officer

Tuesday, March 2, 2021 - 1:00pm

CARLSBAD, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Duane Wilder as the companys Chief Commercial Officer.

Key Points: 
  • CARLSBAD, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Duane Wilder as the companys Chief Commercial Officer.
  • Mr. Wilder joins Acutus with over 25 years of commercial experience in the medical technology industry.
  • Mr. Wilder began his medical technology career at W. Lorenz Surgical in 1994, and previously served our country as a Surface Warfare Officer in the United States Navy.
  • Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated.

Automated External Defibrillators (Public Access) Bill

Saturday, February 27, 2021 - 1:02pm

A Bill to require the installation of automated external defibrillators in public buildings, sporting facilities, schools, higher education and other education and skills facilities, and facilities that provide care to vulnerable people; and to make associated provision about training and signage.

Key Points: 

A Bill to require the installation of automated external defibrillators in public buildings, sporting facilities, schools, higher education and other education and skills facilities, and facilities that provide care to vulnerable people; and to make associated provision about training and signage.

Global $22.8 Billion Defibrillator (ICD, External Defibrillator) Market to 2028: COVID-19 Pandemic Further Accentuates the Need for Defibrillators

Thursday, February 25, 2021 - 6:15pm

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Defibrillator Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Defibrillator Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global defibrillator market size is expected to reach USD 22.2 billion by 2028.
  • The rising demand for handling sudden cardiac arrests is leading to innovation in implantable as well as external defibrillators.
  • This significantly enhanced the company's cardiac solutions offerings and allowed it to commercialize the products in the market.

Rashad Khazi Syed MD is recognized by Continental Who's Who

Thursday, February 25, 2021 - 2:49am

MILWAUKEE, Feb. 24, 2021 /PRNewswire/ --Rashad Khazi Syed MD is being recognized by Continental Who's Who as a Top Cardiac Electrophysiologist for his professional excellence in the field of Medicine and at Ascension Columbia St. Mary's Milwaukee.

Key Points: 
  • MILWAUKEE, Feb. 24, 2021 /PRNewswire/ --Rashad Khazi Syed MD is being recognized by Continental Who's Who as a Top Cardiac Electrophysiologist for his professional excellence in the field of Medicine and at Ascension Columbia St. Mary's Milwaukee.
  • Located in Milwaukee County, Ascension Columbia St. Mary's Milwaukee Water Tower Medical Commons offers a full spectrum of personalized, compassionate healthcare services.
  • The doctors and nurse practitioners provide a wide range of services, including family-focused care, heart care, women's health, and rehabilitation therapy.
  • Dr. Rashad Khazi Syed is a board-certified cardiac electrophysiologist with Ascension Columbia St. Mary's Milwaukee Water Tower Medical Commons for the past six years.

Study Published in JAMA Cardiology Finds Zio by iRhythm Proactively Identifies Atrial Fibrillation, Increases Detection Tenfold

Wednesday, February 24, 2021 - 4:00pm

The transatlantic clinical trial found that Zio by iRhythm , an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.

Key Points: 
  • The transatlantic clinical trial found that Zio by iRhythm , an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.
  • The study results lend support for Zio as a screening tool for early detection of AF.
  • iRhythm is a leading digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed.
  • The company believes improvements in arrhythmia detection and characterization have the potential to change the clinical management of patients.

CB Scientific, Inc. Discusses the Potential of Their Proprietary Cardiac Event Monitor, my-Cam, with The Stock Day Podcast

Tuesday, February 23, 2021 - 2:00pm

asked Jolly, after commenting on the Company's proprietary my-Cam cardiac event monitor.

Key Points: 
  • asked Jolly, after commenting on the Company's proprietary my-Cam cardiac event monitor.
  • "Today, with ambulatory remote cardiac event monitoring, there are actually four modalities that are offered," explained Martin, before elaborating on these technologies.
  • "Our device is cardiac event monitoring, which is a device that can be worn for up to 30 days," said Martin.
  • "That particular application has evolved into what's called cardiac event monitoring, which is on the marketplace today, primarily in the US."

Global Defibrillator (ICD, External Defibrillator) Market Report, 2021-2028: Legislative Reforms, Presence of Integrated Technology, Increasing Incidences of SCA in Younger Population - ResearchAndMarkets.com

Tuesday, February 23, 2021 - 9:58am

The global defibrillator market size is expected to reach USD 22.2 billion by 2028.

Key Points: 
  • The global defibrillator market size is expected to reach USD 22.2 billion by 2028.
  • Factors contributing to the growth of this market include supportive legislative reforms, rising incidences of sudden cardiac arrests in the region, presence of integrated technology, and the rising awareness for cardiac conditions.
  • The rising demand for handling sudden cardiac arrests is leading to innovation in implantable as well as external defibrillators.
  • This significantly enhanced the company's cardiac solutions offerings and allowed it to commercialize the products in the market.

RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity

Thursday, February 18, 2021 - 1:01pm

MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ -- RhythMedix , a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity.

Key Points: 
  • MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ -- RhythMedix , a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity.
  • The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring without the need for an additional phone or communication device.
  • The sleek, one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event and MCT) that connects patients and clinicians for improved patient care.
  • RhythMedix, a privately owned medical device manufacturer, provides innovative technology to transform the medical monitoring industry and improve patient outcomes.

AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions

Tuesday, February 16, 2021 - 2:58pm

The collaboration will translate AliveCor's potassium detection technology and science, which enables potassium measurement outside of blood draws, into real-world disease management applications and solutions.

Key Points: 
  • The collaboration will translate AliveCor's potassium detection technology and science, which enables potassium measurement outside of blood draws, into real-world disease management applications and solutions.
  • Kardia-K is being built using AliveCor's proprietary deep neural network, and analyzes electrocardiograms (ECGs) to measure a patient's potassium levels without requiring any blood from the patient.
  • AliveCor's neural network was trained in collaboration with Mayo Clinic using more than 1.5 million ECGs and was validated on approximately 62,000 ECGs.
  • "Our collaboration with AstraZeneca exemplifies how pharmaceutical and digital health companies can work together to drive the future of medicine."